Research review focuses on the use of psilocybin for treatment of depression

A growing body of evidence suggests that psychedelic drugs may be useful in treating various mental health conditions.

Scientific sleuths, adults with cerebral palsy, and RFK, Jr.

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Need a distraction from your election anxiety?

November 4, 2024

Sen. Warren attacks GSK’s decision to shift inhaler from brand to authorized generic

GSK’s decision to switch patients from its brand-name Flovent inhaler to an authorized generic is an “insidious” tactic that “may cause millions of children” to

March 6, 2024

Osteoarthritis by Purecell Group for Osteoarthritis: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

January 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.